Stacey Moulder

538 total citations
6 papers, 400 citations indexed

About

Stacey Moulder is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Stacey Moulder has authored 6 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Stacey Moulder's work include HER2/EGFR in Cancer Research (2 papers), Estrogen and related hormone effects (2 papers) and Cancer Treatment and Pharmacology (2 papers). Stacey Moulder is often cited by papers focused on HER2/EGFR in Cancer Research (2 papers), Estrogen and related hormone effects (2 papers) and Cancer Treatment and Pharmacology (2 papers). Stacey Moulder collaborates with scholars based in United States and Germany. Stacey Moulder's co-authors include L. Hsu, Funda Meric‐Bernstam, Kristine Broglio, W. Fraser Symmans, Ana M. González-Angulo, Constance T. Albarracin, Wendy A. Woodward, Gabriel N. Hortobágyi, Lajos Pusztai and Ludwig Kiesel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Stacey Moulder

6 papers receiving 391 citations

Peers

Stacey Moulder

ONCOL

CR

MB

PRM

GENET

Francesca Conti United States

Pauline K. Park United States

K E Driver United Kingdom

Jian Chang United States

Arrate Plazaola Spain

Dehong Zou China

N. Vidnovic United States

Kathleen Woods Ignatoski United States

Ravat Panvichian Thailand

Francesca Conti United States

Stacey Moulder

239 ×0.9

ONCOL

141 ×0.7

CR

88 ×0.8

MB

40 ×0.5

PRM

47 ×0.9

GENET

Citations per year, relative to Stacey Moulder Stacey Moulder (= 1×) peers Francesca Conti

Countries citing papers authored by Stacey Moulder

Since Specialization

Citations

This map shows the geographic impact of Stacey Moulder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacey Moulder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacey Moulder more than expected).

Fields of papers citing papers by Stacey Moulder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacey Moulder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacey Moulder. The network helps show where Stacey Moulder may publish in the future.

Co-authorship network of co-authors of Stacey Moulder

This figure shows the co-authorship network connecting the top 25 collaborators of Stacey Moulder. A scholar is included among the top collaborators of Stacey Moulder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacey Moulder. Stacey Moulder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Hong, David S., Haby Henary, G. S. Falchook, et al.. (2014). First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors. Investigational New Drugs. 32(6). 1204–1212. 58 indexed citations

2.

Wheler, Jennifer J., Stacey Moulder, Aung Naing, et al.. (2013). Abstract 3514: A dose-escalation study of anastrozole and everolimus in patients with advanced gynecologic and breast malignancies: tolerance, biological activity, and molecular alterations in the PI3K/AKT/mTOR pathway.. Cancer Research. 73(8_Supplement). 3514–3514. 1 indexed citations

3.

Moulder, Stacey, et al.. (2010). Abstract P6-15-01: A Phase 1b Study To Assess the Safety and Tolerability of the PARP Inhibitor Iniparib (BSI-201) in Combination with Irinotecan for the Treatment of Patients with Metastatic Breast Cancer (MBC). Cancer Research. 70(24_Supplement). P6–15. 9 indexed citations

4.

Liedtke, C, Kristine Broglio, Stacey Moulder, et al.. (2009). Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer. Annals of Oncology. 20(12). 1953–1958. 228 indexed citations

5.

Moulder, Stacey, et al.. (2007). Advances in the Treatment of Breast Cancer. Clinical Pharmacology & Therapeutics. 83(1). 26–36. 103 indexed citations

6.

Camacho, Luis H., David S. Hong, Carolina Gutiérrez, et al.. (2007). Organic arsenic in patients (pts) with advanced solid tumors: Phase-1 results of zio-101 (s-dimethylarsino-glutathione). Journal of Clinical Oncology. 25(18_suppl). 3554–3554. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact